CoChat

Differential role of angiotensin II receptor subtypes on endothelial superoxide formation

Open access
Sohn, Hae Young, Raff, Ulrike, Hoffmann, Anke, Gloe, Torsten, Heermeier, Kathrin, Galle, Jan, Pohl, Ulrich · 2000 · British Journal of Pharmacology
Cited by 105

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The physiological role of the angiotensin II AT2 receptor subtype is not fully characterized. We studied whether AT2 receptor could antagonize AT1 mediated superoxide formation in endothelial cells. In quiescent human umbilical vein endothelial cells (HUVEC) superoxide formation was measured after long‐term incubation (6 h) with angiotensin II in the presence or absence of its receptor blocker candesartan (AT1) or PD123319 (AT2) using the cytochrome c assay. In separate experiments, the effects of AT2 mediated effects on activities of cellular phosphates including the src homology 2 domain containing phosphatases (SHP‐1) was studied. The basal superoxide formation (0.19±0.03 nmol superoxide mg protein−1 min−1) in HUVEC was increased by 37.1% after exposure to angiotensin II (100 n M,) which was due to an activation of a NAD(P)H oxidase. This was abolished by candesartan (1 μ M) as well as the tyrosine kinase inhibitor genistein. In contrast, blockade of AT2 receptors by PD123319 enhanced the superoxide formation by 73.7% in intact cells. Stimulation of AT2 went along with an increased activity of tyrosine phosphatases in total cell lysates (29.8%) and, in particular, a marked stimulation of src homology 2 domain containing phosphatases (SHP‐1, by 293.4%). The tyrosine phosphatase inhibitor vanadate, in turn, prevented the AT2 mediated effects on superoxide formation. The expression of both angiotensin II receptor subtypes AT1 and AT2 was confirmed by RT–PCR analysis. It is concluded that AT2 functionally antagonizes the AT1 induced endothelial superoxide formation by a pathway involving tyrosine phosphatases. British Journal of Pharmacology (2000) 131, 667–672; doi:10.1038/sj.bjp.0703566

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0703566

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 105

Metadata

Authors
Sohn, H. Y., Raff, U., Hoffmann, A., Gloe, T., Heermeier, K., Galle, J., & Pohl, U.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2000-10
Volume
131
Issue
4
Pages
667-672
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2160100683
Cited by
105
References
2
FWCI
5.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. https://app.cochat.ai/papers/10.1038/sj.bjp.0703566
The paper
Sohn, H. Y., Raff, U., Hoffmann, A., Gloe, T., Heermeier, K., Galle, J., & Pohl, U. (2000). Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703566

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.